Brought to you by 
Norak brings in $13mm in Series B round
19 Mar 2002
Executive Summary
Norak Biosciences (develops drugs that regulate G protein-coupled receptors--GPCRs) completed a Series B financing, bringing in $13mm. New investors included Noro-Moseley Partners (which led the round), Mitsui & Co. Venture Partners, Alexandria Real Estate Equities, and Koch Enterprises. Also participating were return investors Intersouth Partners and Aurora Funds.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Norak brings in $13mm in Series B round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice